NGM Biopharmaceuticals, Inc. Cash Flow from Investing Activities 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. cash flow from investing activities from 2019 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| NGM Biopharmaceuticals, Inc. Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $114 |
| 2022 | $14 |
| 2021 | $-72 |
| 2020 | $-51 |
| 2019 | $49 |
| 2018 | $39 |
| 2017 | $-3 |
